                         SEQUENCE LISTING

<110>  Infinitec Activos, S.L.
       Peptidepharma Nova, S.L.
 
<120>  Targeted capsules to fibroblast for the delivery of antiaging 
       agents in the skin

<130>  P11593PC00

<150>  EP15382077.4
<151>  2015-02-25

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide 1

<400>  1

Lys Phe Asn Leu Pro Leu Gly Asn Tyr Lys Lys Pro 
1               5                   10          


<210>  2
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide 2

<400>  2

Lys Ala Asn Leu Pro Leu Gly Asn Tyr Lys Lys Pro 
1               5                   10          


<210>  3
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide 3

<400>  3

Lys Phe Ala Leu Pro Leu Gly Asn Tyr Lys Lys Pro 
1               5                   10          


<210>  4
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide 4

<400>  4

Lys Phe Asn Ala Pro Leu Gly Asn Tyr Lys Lys Pro 
1               5                   10          


<210>  5
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide 5

<400>  5

Lys Phe Asn Leu Ala Leu Gly Asn Tyr Lys Lys Pro 
1               5                   10          


<210>  6
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide 6

<400>  6

Lys Phe Asn Leu Pro Ala Gly Asn Tyr Lys Lys Pro 
1               5                   10          


<210>  7
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide 7

<400>  7

Lys Phe Asn Leu Pro Leu Ala Asn Tyr Lys Lys Pro 
1               5                   10          


<210>  8
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide 8

<400>  8

Lys Phe Asn Leu Pro Leu Gly Ala Tyr Lys Lys Pro 
1               5                   10          


<210>  9
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide 9

<400>  9

Lys Phe Asn Leu Pro Leu Gly Asn Ala Lys Lys Pro 
1               5                   10          


<210>  10
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide 10

<400>  10

Lys Phe Asn Leu Pro Leu Gly Asn Tyr Ala Lys Pro 
1               5                   10          


<210>  11
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide 11

<400>  11

Lys Phe Asn Leu Pro Leu Gly Asn Tyr Lys Ala Pro 
1               5                   10          


<210>  12
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide 12

<400>  12

Lys Phe Asn Leu Pro Leu Gly Asn Tyr Lys Lys Ala 
1               5                   10          


<210>  13
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Substrate

<400>  13

Cys Ala Gly Ala Gly Ala Ile Glu Thr Asp Lys Glu Tyr Tyr Thr Val 
1               5                   10                  15      


Lys Asp 
        


